Posted in | News | Optics and Photonics

Lockheed Martin to Support U.S. Army's Electro-Optical Fire Control System

The U.S. Army awarded Lockheed Martin (NYSE: LMT) a contract to support the Target Acquisition Designation Sight/Pilot Night Vision Sensor (TADS/PNVS) and Modernized TADS/PNVS (M-TADS/PNVS) systems on the AH-64 Apache helicopter at the Arizona Support Center.  The contract has a potential value of $36.8 million for the next three years.

M-TADS/PNVS

Located in Gilbert, AZ, the Arizona Support Center inducts, refurbishes and modifies legacy TADS/PNVS components to incorporate into the modernized system (M-TADS/PNVS).  The contract includes fielding activities associated with the modernization effort.  Fielding activities will include sending a team of Orlando-based product support technicians to U.S. Army Apache locations worldwide to install and test newly modified M-TADS/PNVS systems on the aircraft.

"M-TADS/PNVS has consistently proven its effectiveness on the battlefield," said David Belvin, director of Apache M-TADS/PNVS and Support Programs at Lockheed Martin Missiles and Fire Control.  "This contract allows for the continued fielding of this crucial capability to the Warfighter."

M-TADS/PNVS is an advanced electro-optical fire control system that provides AH-64D Apache helicopter pilots with advanced targeting and pilotage capabilities that result in enhanced mission effectiveness during day, night and/or adverse-weather missions.

"Every Apache battalion deployed in support of current operations in Iraq and Afghanistan is equipped with the M-TADS/PNVS system," said Col. Shane Openshaw, Program Manager for Apache.  "The system is the number one Apache pilot request since 1997.  Apache performance remains outstanding from the factory to the foxhole."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.